跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
STAPHYLEX 250 capsule
Approved
STANDARD
STAPHYLEX 250 capsule
Alphapharm Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
6f5a2fc210b7dea3
Company
Alphapharm Pty Ltd
Type
Standard
Approval Details
Approval Id
6f5a2fc210b7dea3
Product Name
STAPHYLEX 250 capsule
Artg Id
17683
Artg Name
STAPHYLEX 250 FLUCLOXACILLIN 250mg (as sodium) capsule blister pack
Sponsor
Alphapharm Pty Ltd
Company Detail Path
/organization/alphapharm-pty-ltd
Artg Date
1991-09-20
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/49f1b3abb84957e4a411a856946324de.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/dc77a558d98e0e1aa7f763ae436ff199.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
6f5a2fc210b7dea3
Type
Standard
Back to TGA Approvals
STAPHYLEX 250 capsule - TGA Drug Approval Details